Related Experiment Video
Updated: Jun 24, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Vaccine production in Neurospora crassa
Silke Allgaier1, Rebecca D Taylor, Yuliya Brudnaya
1Neugenesis Corporation, Burlingame, CA, USA.
Abstract:
We have chosen to use the filamentous fungus Neurospora crassa to produce subunit vaccines. Here we describe the production and purification of Influenza hemagglutinin and neuraminidase antigens in N. crassa. The N. crassa system used by Neugenesis offers many advantages over other systems for production of recombinant protein. In contrast to mammalian cell culture, N. crassa can be grown in a rapid and economic manner, generating large amounts of recombinant protein in simple, defined medium. Vaccines, therefore, can be produced more rapidly and at lower cost than conventional cell culture or egg-based systems. This has important applications to tailoring the seasonal vaccine supply and responding to new pandemics.
More Related Videos
Related Concept Videos
Vaccine Production
Production of Antibiotics
Endospores and Sporulation
Bioreactor Controls-III
Cryptococcal Meningitis
Fungal Phylum Microsporidia

